Quick Answer
Adicet Bio, Inc. reported Operating Income of -$122.11 million for fiscal year 2025.
Adicet Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$122.11M | +4.3% |
| 2024 | -$127.61M | +16.1% |
| 2023 | -$152.04M | -109.6% |
| 2022 | -$72.55M | -18.1% |
| 2021 | -$61.43M | -56.8% |
| 2020 | -$39.19M | -24.9% |
| 2019 | -$31.39M | -109.8% |
| 2018 | -$14.96M | +20.7% |
| 2017 | -$18.88M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.95M | +15.7% | +13.7% |
| June 30, 2025 | -$32.39M | +1.4% | -8.4% |
| March 31, 2025 | -$29.89M | +3.2% | +9.9% |
| September 30, 2024 | -$33.15M | +36.6% | -0.9% |
| June 30, 2024 | -$32.85M | +5.8% | -6.4% |
| March 31, 2024 | -$30.87M | +7.4% | +40.9% |
| September 30, 2023 | -$52.26M | -127.4% | -49.8% |
| June 30, 2023 | -$34.89M | -53.7% | -4.7% |
- Adicet Bio, Inc. showed an increase of +4.3% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Adicet Bio, Inc.’s operating income has declined by 546.7% (from -$18.88 million to -$122.11 million).
- The most recent figure is from Adicet Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: